ロード中...
The surge in biosimilars: considerations for effective pharmacovigilance and EU regulation
The development of biosimilars is growing rapidly, especially in Europe. They are a cost-effective alternative to original biological medicines and can help improve patient access to these therapies. The European Medicines Agency (EMA) has been the first to issue scientific guidelines related to reg...
保存先:
| 出版年: | Ther Adv Drug Saf |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166315/ https://ncbi.nlm.nih.gov/pubmed/30283628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098618790442 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|